Global Fetal Bovine Serum (FBS) for Cell Culture Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Fetal Bovine Serum (FBS) for Cell Culture market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Fetal Bovine Serum (FBS) is a widely-used growth supplement for cell culture media that provides many defined and undefined components that have been shown to satisfy specific metabolic requirements for the culture of cells.
Fetal bovine serum is the remained blood fraction after the natural coagulation of blood, which is obtained by centrifugation to remove any remaining red blood cells. Fetal bovine serum has been irreplaceable media in cell culture industry. The raw material of fetal bovine serum is fetal bovine blood. The FBS suppliers make contract with beef processer or agent and gather fetal bovine blood at certain time. The production of FBS is quite seasonal because the raw material source can only be acquired twice a year. The primary factor and main market-driver is the beef processing industry, since FBS is produced as a byproduct of this industry.
The manufacturers of FBS are concentrated in North America, Australia, New Zealand and South America. The growth of FBS production has been modest for the past years, due to the deficiency of raw material supply. The primary application of FBS is to fortify cell culture media. It is the most common media supplement used for cell culture.
The Global Info Research report includes an overview of the development of the Fetal Bovine Serum (FBS) for Cell Culture industry chain, the market status of Scientific Research (USA-sourced, South America-sourced), Industrial Production (USA-sourced, South America-sourced), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Fetal Bovine Serum (FBS) for Cell Culture.
Regionally, the report analyzes the Fetal Bovine Serum (FBS) for Cell Culture markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Fetal Bovine Serum (FBS) for Cell Culture market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Fetal Bovine Serum (FBS) for Cell Culture market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Fetal Bovine Serum (FBS) for Cell Culture industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., USA-sourced, South America-sourced).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Fetal Bovine Serum (FBS) for Cell Culture market.
Regional Analysis: The report involves examining the Fetal Bovine Serum (FBS) for Cell Culture market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Fetal Bovine Serum (FBS) for Cell Culture market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Fetal Bovine Serum (FBS) for Cell Culture:
Company Analysis: Report covers individual Fetal Bovine Serum (FBS) for Cell Culture manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Fetal Bovine Serum (FBS) for Cell Culture This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Scientific Research, Industrial Production).
Technology Analysis: Report covers specific technologies relevant to Fetal Bovine Serum (FBS) for Cell Culture. It assesses the current state, advancements, and potential future developments in Fetal Bovine Serum (FBS) for Cell Culture areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Fetal Bovine Serum (FBS) for Cell Culture market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Fetal Bovine Serum (FBS) for Cell Culture market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
USA-sourced
South America-sourced
Australia-sourced
Others
Market segment by Application
Scientific Research
Industrial Production
Major players covered
Thermo Fisher
Merck
Cytiva
Biowest
Moregate BioTech
ExCell Bio
Internegocios
Tissue Culture Biologicals
Gemini
Corning
Biological Industries
VWR
Bovogen
R&D Systems
Seroxlab
Animal Technologies
RMBIO
Bio Nutrientes Brasil
Serana
WISENT
PAN-Biotech
Zhejiang Tianhang Biotechnology
Lanzhou Minhai
Peak Serum
Jin Yuan Kang
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fetal Bovine Serum (FBS) for Cell Culture product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fetal Bovine Serum (FBS) for Cell Culture, with price, sales, revenue and global market share of Fetal Bovine Serum (FBS) for Cell Culture from 2018 to 2023.
Chapter 3, the Fetal Bovine Serum (FBS) for Cell Culture competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fetal Bovine Serum (FBS) for Cell Culture breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Fetal Bovine Serum (FBS) for Cell Culture market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fetal Bovine Serum (FBS) for Cell Culture.
Chapter 14 and 15, to describe Fetal Bovine Serum (FBS) for Cell Culture sales channel, distributors, customers, research findings and conclusion.